CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- 4 Open-market buy Director bought 1,000 shares at $5.39 ($5,386)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $5.10 ($5,100)
- 4 Open-market buy Director bought 1,500 shares at $5.40 ($8,100)
- 4 Open-market buy Director bought 1,000 shares at $5.37 ($5,370)
- 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
- 8-K Event Other events
- 4 Open-market buy CEO and CFO bought 2,000 shares at $5.40 ($10,795)
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 424B3 Offering Prospectus
- SC 13D Stake Beneficial Ownership Report
- 4 Option exercise 10% owner acquired 129,400 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Bylaws or fiscal year change · Other events
- 4 Open-market buy CEO and CFO bought 16,667 shares at $4.60 ($76,710)
- 4 Open-market buy Director bought 8,333 shares at $4.60 ($38,353)
- 3/A Insider 3/A
- 4 Option exercise CEO and CFO acquired 1,665,124 shares (option exercise)
Page 12 of 14 · 279 filings